IRadimed CEO, President and Chairman Roger E. Susi reports common stock disposal; $746,000 total value

Reuters03-26
IRadimed CEO, President and Chairman Roger E. Susi reports common stock disposal; $746,000 total value
  • Roger E. Susi, CEO, President and Chairman of IRadimed, reported sales of common stock on March 23, 2026 and March 24, 2026.
  • The filing shows 2,950 shares were sold at a weighted average price of USD 99.58 and 750 shares were sold at a weighted average price of USD 100.7.
  • It also reports sales of 1,300 shares at a weighted average price of USD 102.02 and 1,585 shares at a weighted average price of USD 100.03.
  • Additional sales included 915 shares at a weighted average price of USD 100.71, with 2,232,500 shares held indirectly afterward through the Phillip Susi 2008 Dynasty Trust.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRadimed Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001613801-26-000018), on March 25, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment